SEC Selectivity and Method Development For Biomolecules
Phenomenex: SEC Selectivity and Method Development For Biomolecules
Key Learning Points:
-
Theory behind size exclusion chromatography
-
A brief overview on mAbs and it’s characterization requirements
-
LC system, LC Column and Stationary phase effects and considerations
-
Mobile phase considerations and method development pointers
Presenter: Namrata Saxena (Technical Manager, Phenomenex)
Namrata Saxena is a Technical Manager - Asia/Pacific” with Phenomenex and is based in Sydney, Australia. She has a post graduate degree with a specialization in Analytical Chemistry, with extensive experience in the Liquid chromatography domain, and her current focus is in Omics and Biologics field.
Before joining Phenomenex she had worked as “Product Specialist” and spent several years in column chemistry, column manufacturing and method development in the application and manufacturing labs of Bischoff Chromatography, Germany.
In her current role, she provides product selection, method development, training and troubleshooting support to customers as well as Phenomenex Sales Consultants globally.